-
公开(公告)号:DE19614533A1
公开(公告)日:1997-10-16
申请号:DE19614533
申请日:1996-04-12
Applicant: BASF AG
Inventor: KLINGE DAGMAR DR , AMBERG WILHELM DR , BAUMANN ERNST DR , KLING ANDREAS DR , RIECHERS HARTMUT DR , UNGER LILIANE DR , RASCHACK MANFRED DR , HERGENROEDER STEFAN , SCHULT SABINE DR
IPC: A61K31/00 , A61K31/505 , A61K31/517 , A61P5/42 , A61P9/10 , A61P13/00 , A61P13/12 , C07D217/22 , C07D239/34 , C07D239/48 , C07D239/52 , C07D239/56 , C07D239/60 , C07D239/70 , C07D239/80 , C07D239/96 , C07D251/20 , C07D251/22 , C07D251/30 , C07D251/38 , C07D251/52 , C07D403/12 , C07D405/12 , C07D471/04 , C07D487/04 , C07D491/04 , C07D491/044 , C07D239/32 , A61K31/53 , A61K31/44 , A61K31/47
Abstract: The present invention relates to carboxylic acid derivatives of the formula (I) in which the radicals have the meaning given in the description, the production of these compounds and their use as medicaments.
-
公开(公告)号:AT130851T
公开(公告)日:1995-12-15
申请号:AT92103514
申请日:1992-02-29
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , SCHULT SABINE DR , BEHL BERTHOLD DR , KIRCHENGAST MICHAEL DR
IPC: A61K31/445 , A61K31/4427 , A61K31/4465 , A61K31/4468 , A61K31/451 , A61K31/495 , A61K31/496 , A61P9/06 , C07D211/26 , C07D211/56 , C07D211/58 , C07D401/04 , C07D401/06 , C07D211/00 , C07D215/00
-
公开(公告)号:DK0481299T3
公开(公告)日:1994-09-12
申请号:DK91116915
申请日:1991-10-04
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , SCHULT SABINE DR , BINDER RUDOLF DR , RASCHACK MANFRED DR , REINHARDT ROLAND DR , SEEMANN DIETMAR DR
IPC: A61K31/445 , A61K31/4427 , A61K31/4468 , A61P9/00 , C07D211/58 , C07D401/12 , A61K31/44
Abstract: Phenylpiperidylamines of the formula I I R1 is H, NO2, R4SO2NH, N=C, CF3, CF3O, F, Cl, Br, C1-C4-alkyl, R3O, CO2R3, CHO, CH=NOR3, CH3OR3 and R2 is H, F, Cl, Br, C1-C4-alkyl or R4O, where R1 and R2 are not both H, R3 is H or R4, R4 is C1-C4-alkyl or phenyl, n is 1, 2, 3 or 4 and Ar is and the physiologically tolerated salts thereof, are used as active ingredients in drugs.
-
公开(公告)号:CZ9800641A3
公开(公告)日:1998-09-16
申请号:CZ64198
申请日:1996-08-29
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , KLING ANDREAS DR , KLINGE DAGMAR DR , REICHERS HARTMUT DR , UNGER LILIANE DR , RASCHACK MANFRED DR , HERGENRODER STEFAN , ELGER BERND , SCHULT SABINE DR
IPC: C07D317/02 , A61K31/00 , A61K31/19 , A61K31/192 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/35 , A61K31/352 , A61K31/357 , A61K31/36 , A61K31/435 , A61K31/44 , A61K31/505 , A61P9/00 , A61P9/08 , C07C53/134 , C07C57/30 , C07C57/32 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07C255/00 , C07D213/55 , C07D213/64 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D257/04 , C07D307/79 , C07D317/50 , C07D317/60 , C07D319/02 , C07D319/18
CPC classification number: C07D213/64 , C07C57/30 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07D213/55 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D307/79 , C07D317/60 , C07D319/18
-
公开(公告)号:CZ64198A3
公开(公告)日:1998-09-16
申请号:CZ64198
申请日:1996-08-29
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , KLING ANDREAS DR , KLINGE DAGMAR DR , REICHERS HARTMUT DR , UNGER LILIANE DR , RASCHACK MANFRED DR , HERGENRODER STEFAN , ELGER BERND , SCHULT SABINE DR
IPC: C07D317/02 , A61K31/00 , A61K31/19 , A61K31/192 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/35 , A61K31/352 , A61K31/357 , A61K31/36 , A61K31/435 , A61K31/44 , A61K31/505 , A61P9/00 , A61P9/08 , C07C53/134 , C07C57/30 , C07C57/32 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07C255/00 , C07D213/55 , C07D213/64 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D257/04 , C07D307/79 , C07D317/50 , C07D317/60 , C07D319/02 , C07D319/18
Abstract: PCT No. PCT/EP96/03793 Sec. 371 Date Feb. 24, 1998 Sec. 102(e) Date Feb. 24, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/09294 PCT Pub. Date Mar. 13, 1997Carboxylic acid derivatives of the formula I here R1 is a tetrazole [sic], nitrile [sic], a group COOH or a radical which can be hydrolyzed to COOH, and the other substituents have the meaning explained in the description.
-
公开(公告)号:DE59102245D1
公开(公告)日:1994-08-25
申请号:DE59102245
申请日:1991-10-04
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , SCHULT SABINE DR , BINDER RUDOLF DR , RASCHACK MANFRED DR , REINHARDT ROLAND DR , SEEMANN DIETMAR DR
IPC: A61K31/445 , A61K31/4427 , A61K31/4468 , A61P9/00 , C07D211/58 , C07D401/12
Abstract: Phenylpiperidylamines of the formula I I R1 is H, NO2, R4SO2NH, N=C, CF3, CF3O, F, Cl, Br, C1-C4-alkyl, R3O, CO2R3, CHO, CH=NOR3, CH3OR3 and R2 is H, F, Cl, Br, C1-C4-alkyl or R4O, where R1 and R2 are not both H, R3 is H or R4, R4 is C1-C4-alkyl or phenyl, n is 1, 2, 3 or 4 and Ar is and the physiologically tolerated salts thereof, are used as active ingredients in drugs.
-
公开(公告)号:DE4036782A1
公开(公告)日:1992-05-21
申请号:DE4036782
申请日:1990-11-17
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , PHILIPSBORN GERDA VON DR MED , SCHULT SABINE DR , KIRCHENGAST MICHAEL DR
IPC: A61K31/165 , A61K31/00 , A61K31/16 , A61K31/167 , A61K31/40 , A61K31/445 , A61K31/4453 , A61P9/00 , A61P9/06 , C07C233/29 , C07C235/38 , C07D295/08 , C07D295/088 , C07D295/092
Abstract: Substituted anilides of the formula I I (where R1 is C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, halogen, cyano, nitro, C2-C4-alkenyl, C2-C4-alkynyl; X is methylene, ethylene, vinylene; R2 and R3 are each C1-C4-alkyl, C3-C6-cycloalkyl or together are tetra- or pentamethylene; R4 is C1-C4-alkyl, methoxy; n is 2, 3 or 4), and the physiologically tolerated acid addition salts thereof, the pharmaceutical use thereof, drugs produced therefrom and the use thereof for treating cardiac arrhythmias and/or for lowering the heart rate, are described.
-
公开(公告)号:DE4010097A1
公开(公告)日:1991-10-02
申请号:DE4010097
申请日:1990-03-29
Applicant: BASF AG
Inventor: MAY HANS-JOACHIM DR , RASCHACK MANFRED DR , SCHULT SABINE DR
IPC: A61K31/41 , A61P9/00 , A61P9/12 , C07D498/04
Abstract: Compounds of formula (I), where R to R , X, Y and Z have the indicated meaning, and their production are described. The compounds are useful therapeutic agents.
-
公开(公告)号:MY128488A
公开(公告)日:2007-02-28
申请号:MYPI9905192
申请日:1999-11-27
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , KOCK MICHAEL DR , GER THOMAS H XD DR , SCHULT SABINE DR , GRANDEL ROLAND DR , MUELLER REINHOLD DR
IPC: A61P9/00 , A61K20060101 , A61K31/4184 , A61K31/454 , A61K31/496 , A61P20060101 , A61P3/12 , A61P9/10 , A61P13/12 , A61P17/02 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D20060101 , C07D235/30 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: COMPOUNDS OF THE FORMULA IA OR IB(FORMULA)WHERE R1 IS HYDROGEN OR BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, WHERE ONE CARBON ATOM OF THE ALKYL RADICAL MAY FURTHERMORE CARRY OR5 (WHERE R5 IS HYDROGEN OR C1-C4-ALKYL), OR ONE CARBON ATOM IN THE CHAIN MAY ALSO CARRY AN =O GROUP OR A GROUP NR8R9, WHERE R8 AND R9, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR8R9 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE CARBON CHAINS IN R8 OR R9 OR THE RING FORMED BY NR8R9 MAY FURTHERMORE CARRY A RADICAL R6 WHICH, INDEPENDENTLY OF R2, MAY HAVE THE SAME MEANING AS R2,R4 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, CHLORINE, BROMINE, FLUORINE, NITRO, CYANO, NR8R9, NH-CO-R10 OR OR8, WHERE R8 AND R9, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR8R9 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE RING MAY FURTHERMORE CARRY A RADICAL (BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, CO-R41, COOR41 OR PHENYL), AND R10 MAY BE HYDROGEN, C1-C4-ALKYL OR PHENYL AND R41 MAY HAVE THE SAME MEANINGS AS R21,A IS A SATURATED OR MONOUNSATURATED HETEROCYCLIC, 4- TO 8-MEMBERED RING WHICH CONTAINS ONE OR TWO NITROGEN ATOMS, IT BEING POSSIBLE FOR AN OXYGEN OR SULFUR ATOM ADDITIONALLY TO BE INCORPORATED, WHICH OXYGEN OR SULFUR ATOM IS SUBSTITUTED BY R2 AND R3, WHERER2 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C8-ALKYL WHICH MAY FURTHERMORE BE SUBSTITUTED BY R23, AND A CARBON ATOM OF THE CHAIN MAY CARRY AN =O GROUP, C3-C7-CYCLOALKYL-C1-C4-ALKYL,-CO-(NH)0,l-R2l, COOR2l OR PHENYL, WHERE R21 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL,C3-C7-CYCLOALKYL-C1-C4-ALKYL, PHEN-C1-C4-ALKYL, C3-C7-CYCLOALKYL OR PHENYL, AND EACH RADICAL MAY FURTHERMORE CARRY (CH2)0-2-R23, AND THE RESPECTIVE PHENYL RING IN TURN MAY FURTHERMORE BE SUBSTITUTED BY 1, 2 OR 3 OF THE FOLLOWING RADICALS: CHLORINE, FLUORINE, BROMINE, IODINE, BRANCHED ANDSTRAIGHT-CHAIN C1-C4-ALKYL, NITRO, CF3, CYANO, -(CH2)0-2,NR24R25, NH-CO-R10, OR10, COOR10, SO2-C1-C4-ALKYL, SO2PH, SO2NH, NHSO2-C1-C4-ALKYL, NHSO2PH AND CF3, WHERE R24 AND R25, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR24R25 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE RING MAY FURTHERMORE CARRY A RADICAL OF BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, CO-R22, COOR22 (WHERE R22 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, PHENYL-C1-C4-ALKYL, C3-C7-CYCLOALKYL OR PHENYL) OR PHENYL, AND R10 IS HYDROGEN, C1-C4-ALKYL OR PHENYL, ANDR23 IS NR26R27 WHERE R26 AND R27 ARE EACH HYDROGEN, C1-C6-ALKYL, C0-C4-ALKYLPHENYL, WHERE THE PHENYL RING MAY FURTHERMORE BE SUBSTITUTED BY UP TO 3 RADICALS C1, F, BR, I, C1-C4-ALKYL, CF3, CN, SO2-C1-C4-ALKYL, SO2-PHENYL, NO2, NH2, NHCO-C1-C4-ALKYL, NHCO-PHENYL, OH, O-C1-C4-ALKYL, O-C1-C4-ALKYLPHENYL, AND NR26R27 MAY ALSO BE A CYCLIC AMINE HAVING 3 TO 8 MEMBERS, WHERE A FURTHER HETERO ATOM SUCH AS O, N AND S MAY ALSO ADDITIONA1LY BE PRESENT, AND THE RING MAY FURTHERMORE BE SUBSTITUTED BY A RADICAL R28 WHERE R28 MAY BE C1-C4-ALKYL AND C1-C4-ALKYLPHENYL,R3 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C8-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL WHICH IS UNSUBSTITUTED OR SUBSTITUTED BY C1-C6-ALKYL OR C3-C7-CYCLOALKYL WHICH IS UNSUBSTITUTED OR SUBSTITUTED BY C1-C6-ALKYL, WHERE ONE CARBON ATOM OF THE RADICAL MAY FURTHERMORE CARRY A PHENYL RING WHICH IN TURN MAY ALSO BE SUBSTITUTED BY 1,2 OR 3 OF THE FOLLOWING RADICALS: CHLORINE, FLUORINE, BROMINE, IODINE, BRANCHED AND STRAIGHT-CHAIN C1-C4-ALKYL, NITRO, CF3, CYANO, (CH2)0-2, NR32R33, NH-CO-R10, OR10, COOR10, SO2-C1-C4-ALKYL, SO2PH, CH3, SO2NH, NHSO2-C1-C4-ALKYL, NHSO2PH AND CF3, WHERE R32 AND R33, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR32R33 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE RING MAY FURTHERMORE CARRY A RADICAL OF BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, CO-R31, COOR31 OR PHENYL, AND R10 IS HYDROGEN, C1-C4-ALKYL OR PHENYL, AND R31 MAY HAVE THE SAME MEANING AS R21,AND THEIR TAUTOMERIC FORMS, POSSIBLE ENANTIOMERIC AND DIASTEREOMERIC FORMS, THEIR PRODRUGS AND POSSIBLE PHYSIOLOGICALLY TOLERATED SALTS.
-
公开(公告)号:DE59107342D1
公开(公告)日:1996-03-14
申请号:DE59107342
申请日:1991-11-07
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , VON PHILIPSBORN GERDA DR , SCHULT SABINE DR , KIRCHENGAST MICHAEL DR
IPC: A61K31/165 , A61K31/00 , A61K31/16 , A61K31/167 , A61K31/40 , A61K31/445 , A61K31/4453 , A61P9/00 , A61P9/06 , C07C233/29 , C07C235/38 , C07D295/08 , C07D295/088 , C07D295/092
Abstract: Substituted anilides of the formula I I (where R1 is C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, halogen, cyano, nitro, C2-C4-alkenyl, C2-C4-alkynyl; X is methylene, ethylene, vinylene; R2 and R3 are each C1-C4-alkyl, C3-C6-cycloalkyl or together are tetra- or pentamethylene; R4 is C1-C4-alkyl, methoxy; n is 2, 3 or 4), and the physiologically tolerated acid addition salts thereof, the pharmaceutical use thereof, drugs produced therefrom and the use thereof for treating cardiac arrhythmias and/or for lowering the heart rate, are described.
-
-
-
-
-
-
-
-
-